- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02046408
Computer-Facilitated 5A's for Smoking Cessation in Primary Care
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This project develops and tests a computer-facilitated 5A's (CF-5A's) model that administers the 5A's intervention to patients then prompts providers for reinforcing next steps. CF-5A's could efficiently and effectively promote smoking cessation while educating providers about cessation resources and appropriate follow-up. Based on the Technology Acceptance Model, clinically tailored strategies to promote CF-5A's implementation will be developed and tested to ensure the appropriate use and uptake of this new service delivery model. Development of the model, materials, and strategies will occur in years 1 and 2.
Baseline data collection occurs in year 2, followed by a randomized trial of CF- 5A's where the provider is the unit of randomization. Provider use of the 5A's will primarily be assessed with a brief phone call to the patient after the primary care visit has occurred.
Although focused on 5A's for smoking cessation, this study examines the underlying implementation science of computer-aided service delivery models with important implications for the integration of other substance use or behavioral health interventions in primary care. Implementation factors will be assessed using qualitative interviews and brief pre-post surveys.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
San Francisco, California, United States, 94110
- San Francisco General Hospital
-
San Francisco, California, United States, 94115
- UCSF Adult Primary Care Mt. Zion Clinic
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria: All primary care providers and clinic staff are eligible to participate. Patients must have
- a primary care appointment
- smoked a cigarette in past 7 days
- smoked at least 100 cigarettes in lifetime
- speak English or Spanish
- be cognitively able to use computer tablet
Exclusion Criteria:
- Moderate to severe cognitive impairment
- Does not speak English or Spanish
- acute intoxication on alcohol or illicit drugs
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Tablet Intervention
Primary care providers will be randomized into intervention or control conditions.
The patients of intervention providers will be given a computer tablet that provides 5A's for smoking cessation counseling.
Patients of control providers will not receive a tablet intervention.
|
|
|
No Intervention: Control
Primary care providers will be randomized into intervention or control conditions.
The patients of intervention providers will be given a computer tablet that provides 5A's for smoking cessation counseling.
Patients of control providers will not receive a tablet intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
5A's Fidelity
Time Frame: Baseline assessment 2013-14; Intervention 2014-2015
|
Baseline and post-tablet intervention assessments of primary care provider adherence to 5A's protocol for smoking cessation.
Patients are called after their primary care appointment and asked a series of questions to determine if (and which of) the 5A's were used during that visit.
|
Baseline assessment 2013-14; Intervention 2014-2015
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Tablet Usage
Time Frame: 7/2014-7/2015
|
Intervention includes system strategies to improve usage of computer tablets in primary care waiting rooms.
Outcome = tablet saturation or proportion of patients given a tablet.
|
7/2014-7/2015
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Implementation Factors
Time Frame: July 2013-2015
|
Qualitative interview data to assess the utility of the "Technology Acceptance Model" in explaining tablet and 5A's usage.
Variables assessed include perceived usefulness, social norms and influence, and facilitating conditions.
|
July 2013-2015
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jason M Satterfield, PhD, University of California
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1R01DA034253-01 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking Cessation
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
National University of SingaporeRecruitingSmoking &Amp; Tobacco CessationSingapore
-
Nabi BiopharmaceuticalsNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco CessationUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Heidelberg UniversityPfizerTerminatedSmoking | Smoking Cessation | Tobacco Use CessationGermany
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Sultan Qaboos UniversityCompletedSmoking Cessation | Tobacco Use Cessation | Smoking PreventionOman
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedSmoking &Amp; Tobacco CessationUnited States
-
The University of Hong KongCompletedSmoking Cessation Counseling Ability | Smoking Cessation Counseling PracticeHong Kong
Clinical Trials on Computer Tablet
-
Columbia UniversityNational Library of Medicine (NLM); Agency for Healthcare Research and Quality...Completed
-
University College, LondonL.V. Prasad Eye InstituteUnknownChild | Vision, Low | Adolescent DevelopmentUnited Kingdom, India
-
Herlev HospitalTachistaCompleted
-
Joslin Diabetes CenterMassachusetts Institute of TechnologyCompletedType II DiabetesUnited States
-
University Hospital, Basel, SwitzerlandCompleted
-
Johns Hopkins UniversityCompleted
-
University of California, San FranciscoCompleted
-
Istanbul Saglik Bilimleri UniversityCompletedNursing Caries | Procedural Complication | Venipuncture Site ReactionTurkey
-
Seoul National University HospitalSuspendedREM Sleep Behavior DisorderKorea, Republic of
-
Blekinge Institute of TechnologyKristianstad UniversityCompletedPeriodontal Diseases | Gingivitis | Mild Cognitive ImpairmentSweden